Menu

CAPE VERDE

 BULLETIN

Blog posts January 2024

MSCI Completes Acquisition of Fabric

NEW YORK - Wednesday, 03. January 2024 AETOSWire 

(BUSINESS WIRE) -- MSCI Inc. (NYSE: MSCI), a leading provider of mission-critical decision support tools and services for the global investment community, today announced that it has completed its acquisition of Fabric, a wealth technology platfor…

Read more

The ODP Corporation Announces HG Vora Representative Steps Down from Board of Directors

 

BOCA RATON, Fla. - Wednesday, 03. January 2024 AETOSWire 

(BUSINESS WIRE) -- The ODP Corporation (“ODP,” or the “Company”) (NASDAQ:ODP), a leading provider of business services, products and digital workplace technology solutions to businesses and consumers, today announced that, following t…

Read more

The ODP Corporation Announces HG Vora Representative Steps Down from Board of Directors

(BUSINESS WIRE) -- The ODP Corporation (“ODP,” or the “Company”) (NASDAQ:ODP), a leading provider of business services, products and digital workplace technology solutions to businesses and consumers, today announced that, following the expiration of the January 2021 Cooperation Agreement betwee…

Read more

Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna

DARMSTADT, Germany - Thursday, 04. January 2024 


    First-in-class ompenaclid (RGX-202) currently in Phase II development for RAS-mutated advanced or metastatic colorectal cancer
    Collaboration includes exclusive license outside the US with option to co-develop and co-promote ompenaclid in…

Read more

Tecnotree Secures Top Position, Recognized as a Global Leader in Revenue Management by Precision Reports

ESPOO, Finland - Tuesday, 19. December 2023

(BUSINESS WIRE) -- Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, has been recognized as one of the top two companies in revenue management globally, by ‘Precision Reports - Global Telecom Billing and…

Read more

Takeda Receives Positive CHMP Opinion for HYQVIA® as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

OSAKA, Japan & CAMBRIDGE, Mass. - Friday, 15. December 2023


    If Approved, HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Would Offer an up to Once-Monthly Facilitated Subcutaneous At-Home or In-Office Treatment Option
    Positive Opinion Based on Phase 3…

Read more

6 blog posts